Author: Raushanah Najeeullah, ND
A new urine test, MyProstateScore 2.0 (MPS2), offers better accuracy for detecting high-grade prostate cancer compared to current methods. In a recent study involving over 1,500 men, MPS2 reduced unnecessary biopsies by up to 51% while still identifying significant cancers with high sensitivity. This test improves on the PSA test by specifically targeting 17 genes linked to high grade aggressive prostate cancer, making it a promising non-invasive tool for reducing the risks and discomfort associated with prostate cancer screening.
Source: Tosoian JJ, Zhang Y, Xiao L, et al. Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer. JAMA Oncology. 2024-06-01 2024;10(6):726. doi:10.1001/jamaoncol.2024.0455